Basic Information
RNALocate ID: | RLID:01002064 |
RNA Symbol: | hsa-miR-151a-3p |
Localization: | Nucleolus |
RNA Information
RNA Name: | hsa-miR-151 |
RNA ID: | miRBase:MIMAT0000757 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24918059 |
Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
Method: | Microarray |
Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002060 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002061 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002062 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002063 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002613 | Exosome | Peripheral blood mononuclear cells | 19002258 |
RLID:11002614 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002615 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002616 | Exosome | Renal cancer cells | 21670082 |
RLID:11002617 | Exosome | Brain tissue | 23382797 |
RLID:11002618 | Exosome | Plasma | 23663360 |
RLID:11002619 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002620 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002621 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000132 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000434 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-151a-3p | Diffuse large b cell lymphoma | MNDR-E-MI-16747 |
MNDR | hsa-miR-151a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-16748 |
MNDR | hsa-miR-151a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-16749 |
MNDR | hsa-miR-151a-3p | Lymphoma | MNDR-E-MI-16750 |
MNDR | hsa-miR-151a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16751 |
MNDR | hsa-miR-151a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-16752 |
MNDR | hsa-miR-151a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-16753 |
MNDR | hsa-miR-151a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-16754 |
MNDR | hsa-miR-151a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-16755 |
MNDR | hsa-miR-151a-3p | Breast cancer luminal | MNDR-E-MI-16756 |
MNDR | hsa-miR-151a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-16757 |
MNDR | hsa-miR-151a-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-16758 |
MNDR | hsa-miR-151a-3p | Dermatomyositis | MNDR-E-MI-16759 |
MNDR | hsa-miR-151a-3p | Prostate cancer | MNDR-E-MI-16760 |
MNDR | hsa-miR-151a-3p | Gastric cancer | MNDR-E-MI-16761 |
MNDR | hsa-miR-151a-3p | Alzheimer disease | MNDR-E-MI-16762 |
MNDR | hsa-miR-151a-3p | Intracranial aneurysm | MNDR-E-MI-16763 |
MNDR | hsa-miR-151a-3p | Head and neck cancer | MNDR-E-MI-16764 |
MNDR | hsa-miR-151a-3p | Leukemia | MNDR-E-MI-16765 |
MNDR | hsa-miR-151a-3p | Huntington disease | MNDR-E-MI-16766 |
MNDR | hsa-miR-151a-3p | Chorea | MNDR-E-MI-16767 |
MNDR | hsa-miR-151a-3p | Cardiovascular disease | MNDR-E-MI-16768 |
MNDR | hsa-miR-151a-3p | Carotid stenosis | MNDR-E-MI-16769 |
MNDR | hsa-miR-151a-3p | Moyamoya disease | MNDR-E-MI-16770 |
MNDR | hsa-miR-151a-3p | Lung cancer | MNDR-E-MI-16771 |
MNDR | hsa-miR-151a-3p | Parkinson disease | MNDR-E-MI-16772 |
MNDR | hsa-miR-151a-3p | Breast cancer | MNDR-E-MI-16773 |
MNDR | hsa-miR-151a-3p | Pancreatic cancer | MNDR-E-MI-16774 |
MNDR | hsa-miR-151a-3p | Melanoma | MNDR-E-MI-16775 |
MNDR | hsa-miR-151a-3p | Williams syndrome | MNDR-E-MI-16776 |
MNDR | hsa-miR-151a-3p | Rectum adenocarcinoma | MNDR-E-MI-16777 |
MNDR | hsa-miR-151a-3p | Nephroblastoma | MNDR-E-MI-16778 |
MNDR | hsa-miR-151a-3p | Colon cancer | MNDR-E-MI-16779 |
MNDR | hsa-miR-151a-3p | Ischemic attack transient | MNDR-E-MI-16780 |
MNDR | hsa-miR-151a-3p | Colon adenocarcinoma | MNDR-E-MI-16781 |
MNDR | hsa-miR-151a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-16782 |
MNDR | hsa-miR-151a-3p | Familial ovarian cancer | MNDR-E-MI-16783 |
MNDR | hsa-miR-151a-3p | Prostate adenocarcinoma | MNDR-E-MI-16784 |
MNDR | hsa-miR-151a-3p | Kidney cancer | MNDR-E-MI-16785 |
MNDR | hsa-miR-151a-3p | Carcinoma ductal breast | MNDR-E-MI-16786 |
MNDR | hsa-miR-151a-3p | Glioblastoma | MNDR-E-MI-16787 |
MNDR | hsa-miR-151a-3p | Glioma | MNDR-E-MI-16788 |
MNDR | hsa-miR-151a-3p | Osteosarcoma | MNDR-E-MI-16789 |
MNDR | hsa-miR-151a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-16790 |
MNDR | hsa-miR-151a-3p | Meningioma | MNDR-E-MI-16791 |
MNDR | hsa-miR-151a-3p | Liver cancer | MNDR-E-MI-16792 |
MNDR | hsa-miR-151a-3p | Gastric adenocarcinoma | MNDR-E-MI-16793 |
MNDR | hsa-miR-151a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-16794 |
MNDR | hsa-miR-151a-3p | Lung squamous cell carcinoma | MNDR-E-MI-16795 |
MNDR | hsa-miR-151a-3p | Lung adenocarcinoma | MNDR-E-MI-16796 |
MNDR | hsa-miR-151a-3p | Adrenocortical cancer | MNDR-E-MI-16797 |
MNDR | hsa-miR-151a-3p | Thyroid carcinoma | MNDR-E-MI-16798 |
MNDR | hsa-miR-151a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-16799 |
MNDR | hsa-miR-151a-3p | Myasthenia gravis | MNDR-E-MI-16800 |
MNDR | hsa-miR-151a-3p | Carcinoma renal cell | MNDR-E-MI-16801 |
MNDR | hsa-miR-151a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-16802 |
MNDR | hsa-miR-151a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-16803 |
MNDR | hsa-miR-151a-3p | Adenocarcinoma of esophagus | MNDR-E-MI-16804 |
MNDR | hsa-miR-151a-3p | Cholangiocarcinoma | MNDR-E-MI-16805 |
MNDR | hsa-miR-151a-3p | Esophageal cancer | MNDR-E-MI-16806 |
MNDR | hsa-miR-151a-3p | Lung small cell carcinoma | MNDR-E-MI-16807 |
MNDR | hsa-miR-151a-3p | Stomach carcinoma | MNDR-E-MI-16808 |
MNDR | hsa-miR-151a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-16809 |
MNDR | hsa-miR-151a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-16810 |
MNDR | hsa-miR-151a-3p | Acute t cell leukemia | MNDR-E-MI-16811 |
MNDR | hsa-miR-151a-3p | Fibromyalgia | MNDR-E-MI-16812 |
MNDR | hsa-miR-151a-3p | Encephalomyelitis | MNDR-E-MI-16813 |
MNDR | hsa-miR-151a-3p | Breast invasive carcinoma | MNDR-E-MI-16814 |
MNDR | hsa-miR-151a-3p | Hepatocellular carcinoma | MNDR-E-MI-16815 |
MNDR | hsa-miR-151a-3p | Familiar ovarian carcinoma | MNDR-E-MI-16816 |
MNDR | hsa-miR-151a-3p | Rheumatoid arthritis | MNDR-E-MI-16817 |
MNDR | hsa-miR-151a-3p | Malignant pleural mesothelioma | MNDR-E-MI-16818 |
MNDR | hsa-miR-151a-3p | Neuroblastoma | MNDR-E-MI-16819 |
MNDR | hsa-miR-151a-3p | Hodgkin lymphoma | MNDR-E-MI-16820 |
MNDR | hsa-miR-151a-3p | Burkitt lymphoma | MNDR-E-MI-16821 |
MNDR | hsa-miR-151a-3p | Tonsil cancer | MNDR-E-MI-16822 |
MNDR | hsa-miR-151a-3p | Neuromyelitis optica | MNDR-E-MI-16823 |
MNDR | hsa-miR-151a-3p | Skin cutaneous melanoma | MNDR-E-MI-16824 |
MNDR | hsa-miR-151a-3p | Skin melanoma | MNDR-E-MI-16825 |
MNDR | hsa-miR-151a-3p | Acute myelocytic leukemia | MNDR-E-MI-16826 |
MNDR | hsa-miR-151a-3p | Colorectal cancer | MNDR-E-MI-16827 |
MNDR | hsa-miR-151a-3p | Nasopharynx carcinoma | MNDR-E-MI-16828 |
MNDR | hsa-miR-151a-3p | Multiple myeloma | MNDR-E-MI-16829 |
MNDR | hsa-miR-151a-3p | Leukemia lymphoblastic acute | MNDR-E-MI-16830 |
MNDR | hsa-miR-151a-3p | Cardiomegaly | MNDR-E-MI-16831 |
MNDR | hsa-miR-151a-3p | Nasopharyngeal cancer | MNDR-E-MI-16832 |
MNDR | hsa-miR-151a-3p | AIDS dementia complex | MNDR-E-MI-16833 |
MNDR | hsa-miR-151a-3p | Hypersomnolence idiopathic | MNDR-E-MI-16834 |
MNDR | hsa-miR-151a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-16835 |
MNDR | hsa-miR-151a-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16836 |
MNDR | hsa-miR-151a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-16837 |
MNDR | hsa-miR-151a-3p | Stroke lacunar | MNDR-E-MI-16838 |
MNDR | hsa-miR-151a-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-16839 |
MNDR | hsa-miR-151a-3p | Breast cancer her3+ negative | MNDR-E-MI-16840 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CCDC6 | Homo sapiens | RR00291254 |
TOP